{"id":5600,"date":"2025-02-03T10:05:38","date_gmt":"2025-02-03T09:05:38","guid":{"rendered":"https:\/\/cnatm-1.betapage.de\/?p=5600"},"modified":"2025-02-03T10:06:33","modified_gmt":"2025-02-03T09:06:33","slug":"mrna-basierte-therapie-der-hepatitis-b","status":"publish","type":"post","link":"https:\/\/cnatm.de\/en\/mrna-basierte-therapie-der-hepatitis-b\/","title":{"rendered":"mRNA-based therapy of hepatitis B"},"content":{"rendered":"<div data-elementor-type=\"wp-post\" data-elementor-id=\"5600\" class=\"elementor elementor-5600\" data-elementor-settings=\"{&quot;ha_cmc_init_switcher&quot;:&quot;no&quot;}\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-6363f8b elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"6363f8b\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-807a88d\" data-id=\"807a88d\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-0b60e27 elementor-widget elementor-widget-heading\" data-id=\"0b60e27\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">mRNA-based therapy of hepatitis B<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-39021d3 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"39021d3\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-3c861fc\" data-id=\"3c861fc\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-553a889 elementor-widget elementor-widget-spacer\" data-id=\"553a889\" data-element_type=\"widget\" data-widget_type=\"spacer.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t<div class=\"elementor-spacer\">\n\t\t\t<div class=\"elementor-spacer-inner\"><\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-39a4d74 elementor-widget elementor-widget-text-editor\" data-id=\"39a4d74\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p>Hepatitis B is a very common chronic viral disease that is difficult to cure. The established therapy is based on the use of nucleoside analogous that can control virus replication but are not curative. Interferon alpha may cure hepatitis B, but is accompanied by high side effects as it is applied systemically. The aim of this sub-project is to package interferon-encoding mRNAs into nanoparticles and deliver them directly to HBV-infected livers.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-72d739a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"72d739a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-89f255c\" data-id=\"89f255c\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-89a1439 elementor-widget elementor-widget-text-editor\" data-id=\"89a1439\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>Head: Arne Skerra<br \/><\/strong><\/p><p><strong>PIs: <\/strong>Arne Skerra, Ulrike Protzer, Carine Baer de Oliveira Mann<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t<div class=\"elementor-column elementor-col-50 elementor-top-column elementor-element elementor-element-4e4729f\" data-id=\"4e4729f\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-40a2019 elementor-widget elementor-widget-text-editor\" data-id=\"40a2019\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p><strong>\u00a0Industrial partners<\/strong><\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-c9f5e89 elementor-widget elementor-widget-image\" data-id=\"c9f5e89\" data-element_type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"307\" src=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH-1024x307.png\" class=\"attachment-large size-large wp-image-4461\" alt=\"Xlprotein GmbH\" srcset=\"https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH-1024x307.png 1024w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH-300x90.png 300w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH-768x230.png 768w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH-1536x461.png 1536w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH-18x5.png 18w, https:\/\/cnatm.de\/wp-content\/uploads\/2024\/09\/Xlprotein_GmbH.png 2000w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>","protected":false},"excerpt":{"rendered":"<p>mRNA-basierte Therapie der Hepatitis B Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist. Die etablierte Therapie basiert auf der Verwendung von Nukleosid-Analoga, die die Virusvermehrung unterdr\u00fccken k\u00f6nnen, aber nicht heilbar sind. Interferon alpha kann Hepatitis B heilen, ist aber mit starken Nebenwirkungen verbunden, da es systemisch angewendet wird. Ziel dieses [&hellip;]<\/p>","protected":false},"author":11,"featured_media":5601,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[75],"tags":[],"class_list":["post-5600","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-mrna-wirkstoffe-und-andere-prinzipien"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>mRNA-basierte Therapie der Hepatitis B - CNATM<\/title>\n<meta name=\"description\" content=\"Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cnatm.de\/en\/mrna-basierte-therapie-der-hepatitis-b\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"mRNA-basierte Therapie der Hepatitis B - CNATM\" \/>\n<meta property=\"og:description\" content=\"Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cnatm.de\/en\/mrna-basierte-therapie-der-hepatitis-b\/\" \/>\n<meta property=\"og:site_name\" content=\"CNATM\" \/>\n<meta property=\"article:published_time\" content=\"2025-02-03T09:05:38+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-03T09:06:33+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png\" \/>\n\t<meta property=\"og:image:width\" content=\"916\" \/>\n\t<meta property=\"og:image:height\" content=\"660\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Patrizia Torelli\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Patrizia Torelli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/\"},\"author\":{\"name\":\"Patrizia Torelli\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\"},\"headline\":\"mRNA-basierte Therapie der Hepatitis B\",\"datePublished\":\"2025-02-03T09:05:38+00:00\",\"dateModified\":\"2025-02-03T09:06:33+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/\"},\"wordCount\":94,\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png\",\"articleSection\":[\"mRNA Wirkstoffe und andere Prinzipien\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/\",\"url\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/\",\"name\":\"mRNA-basierte Therapie der Hepatitis B - CNATM\",\"isPartOf\":{\"@id\":\"https:\/\/cnatm.de\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png\",\"datePublished\":\"2025-02-03T09:05:38+00:00\",\"dateModified\":\"2025-02-03T09:06:33+00:00\",\"description\":\"Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist.\",\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png\",\"width\":916,\"height\":660,\"caption\":\"mRNA-basierte Therapie der Hepatitis B\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cnatm.de\/#website\",\"url\":\"https:\/\/cnatm.de\/\",\"name\":\"CNATM\",\"description\":\"Cluster for Nucleic Acid Therapeutics Munich\",\"publisher\":{\"@id\":\"https:\/\/cnatm.de\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cnatm.de\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cnatm.de\/#organization\",\"name\":\"CNATM\",\"url\":\"https:\/\/cnatm.de\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"contentUrl\":\"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg\",\"width\":2362,\"height\":479,\"caption\":\"CNATM\"},\"image\":{\"@id\":\"https:\/\/cnatm.de\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e\",\"name\":\"Patrizia Torelli\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cnatm.de\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g\",\"caption\":\"Patrizia Torelli\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"mRNA-basierte Therapie der Hepatitis B - CNATM","description":"Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cnatm.de\/en\/mrna-basierte-therapie-der-hepatitis-b\/","og_locale":"en_US","og_type":"article","og_title":"mRNA-basierte Therapie der Hepatitis B - CNATM","og_description":"Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist.","og_url":"https:\/\/cnatm.de\/en\/mrna-basierte-therapie-der-hepatitis-b\/","og_site_name":"CNATM","article_published_time":"2025-02-03T09:05:38+00:00","article_modified_time":"2025-02-03T09:06:33+00:00","og_image":[{"width":916,"height":660,"url":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png","type":"image\/png"}],"author":"Patrizia Torelli","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Patrizia Torelli","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#article","isPartOf":{"@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/"},"author":{"name":"Patrizia Torelli","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e"},"headline":"mRNA-basierte Therapie der Hepatitis B","datePublished":"2025-02-03T09:05:38+00:00","dateModified":"2025-02-03T09:06:33+00:00","mainEntityOfPage":{"@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/"},"wordCount":94,"publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"image":{"@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png","articleSection":["mRNA Wirkstoffe und andere Prinzipien"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/","url":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/","name":"mRNA-basierte Therapie der Hepatitis B - CNATM","isPartOf":{"@id":"https:\/\/cnatm.de\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage"},"image":{"@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage"},"thumbnailUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png","datePublished":"2025-02-03T09:05:38+00:00","dateModified":"2025-02-03T09:06:33+00:00","description":"Hepatitis B ist eine sehr h\u00e4ufige chronische Viruserkrankung, die schwer zu heilen ist.","inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/mrna-basierte-therapie-der-hepatitis-b\/#primaryimage","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2025\/02\/WP10.png","width":916,"height":660,"caption":"mRNA-basierte Therapie der Hepatitis B"},{"@type":"WebSite","@id":"https:\/\/cnatm.de\/#website","url":"https:\/\/cnatm.de\/","name":"CNATM","description":"Cluster for Nucleic Acid Therapeutics Munich","publisher":{"@id":"https:\/\/cnatm.de\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cnatm.de\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cnatm.de\/#organization","name":"CNATM","url":"https:\/\/cnatm.de\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/","url":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","contentUrl":"https:\/\/cnatm.de\/wp-content\/uploads\/2022\/02\/CNATM-Logo-mit-Zusatz-RGB-bunt-schwarz.jpg","width":2362,"height":479,"caption":"CNATM"},"image":{"@id":"https:\/\/cnatm.de\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/cnatm.de\/#\/schema\/person\/f2fc8eccad93916c1b891b5fef1ac19e","name":"Patrizia Torelli","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cnatm.de\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/87ab0132dfbaaa804847124811e093cdf95fa3b96905aba129559c779a1ff8eb?s=96&d=mm&r=g","caption":"Patrizia Torelli"}}]}},"_links":{"self":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5600","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/comments?post=5600"}],"version-history":[{"count":4,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5600\/revisions"}],"predecessor-version":[{"id":5605,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/posts\/5600\/revisions\/5605"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media\/5601"}],"wp:attachment":[{"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/media?parent=5600"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/categories?post=5600"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cnatm.de\/en\/wp-json\/wp\/v2\/tags?post=5600"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}